Increased extrasynaptic GluN2B expression is involved in cognitive impairment after isoflurane anesthesia

Li,Lunxu; Li,Zhengqian; Cao,Yiyun; Fan,Dongsheng; Chui,Dehua; Guo,Xiangyang

doi:10.3892/etm.2016.3306

Increased extrasynaptic GluN2B expression is involved in cognitive impairment after isoflurane anesthesia

Authors:
- Lunxu Li
- Zhengqian Li
- Yiyun Cao
- Dongsheng Fan
- Dehua Chui
- Xiangyang Guo
View Affiliations

Affiliations: Department of Anesthesiology, Peking University Third Hospital, Beijing 100191, P.R. China, Department of Neurology, Peking University Third Hospital, Beijing 100191, P.R. China, Neuroscience Research Institute and Department of Neurobiology, Key Laboratory for Neuroscience, Ministry of Education and Ministry of Public Health, Peking University Health Science Center, Beijing 100083, P.R. China
Published online on: April 28, 2016 https://doi.org/10.3892/etm.2016.3306
Pages: 161-168
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

There is increasing concern regarding the postoperative cognitive dysfunction (POCD) in the aging population, and general anesthetics are believed to be involved. Isoflurane exposure induced increased N-methyl-D-aspartic acid receptor (NMDAR) GluN2B subunit expression following anesthesia, which was accompanied by alteration of the cognitive function. However, whether isoflurane affects this expression in different subcellular compartments, and is involved in the development of POCD remains to be elucidated. The aims of the study were to investigate the effects of isoflurane on the expression of the synaptic and extrasynaptic NMDAR subunits, GluN2A and GluN2B, as well as the associated alteration of cognitive function in aged rats. The GluN2B antagonist, Ro25-6981, was given to rats exposed to isoflurane to determine the role of GluN2B in the isoflurane-induced alteration of cognitive function. The results showed that spatial learning and memory tested in the Morris water maze (MWM) was impaired at least 7 days after isoflurane exposure, and was returned to control levels 30 days thereafter. Ro25‑6981 treatment can alleviate this impairment. Extrasynaptic GluN2B protein expression, but not synaptic GluN2B or GluN2A, increased significantly after isoflurane exposure compared to non-isoflurane exposure, and returned to control levels approximately 30 days thereafter. The results of the present study indicated that isoflurane induced the prolonged upregulation of extrasynaptic GluN2B expression after anesthesia and is involved in reversible cognitive impairment.

View Figures

View References

1.	Li ZQ, Rong XY, Liu YJ, Ni C, Tian XS, Mo N, Chui DH and Guo XY: Activation of the canonical nuclear factor-κB pathway is involved in isoflurane-induced hippocampal interleukin-1β elevation and the resultant cognitive deficits in aged rats. Biochem Biophys Res Commun. 438:628–634. 2013. View Article : Google Scholar : PubMed/NCBI
2.	Cao Y, Ni C, Li Z, Li L, Liu Y, Wang C, Zhong Y, Cui D and Guo X: Isoflurane anesthesia results in reversible ultrastructure and occludin tight junction protein expression changes in hippocampal blood-brain barrier in aged rats. Neurosci Lett. 587:51–56. 2015. View Article : Google Scholar : PubMed/NCBI
3.	Jevtovic-Todorovic V, Absalom AR, Blomgren K, Brambrink A, Crosby G, Culley DJ, Fiskum G, Giffard RG, Herold KF, Loepke AW, et al: Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar. Br J Anaesth. 111:143–151. 2013. View Article : Google Scholar : PubMed/NCBI
4.	Rappaport BA, Suresh S, Hertz S, Evers AS and Orser BA: Anesthetic neurotoxicity-clinical implications of animal models. N Engl J Med. 372:796–797. 2015. View Article : Google Scholar : PubMed/NCBI
5.	Zurek AA, Yu J, Wang DS, Haffey SC, Bridgwater EM, Penna A, Lecker I, Lei G, Chang T, Salter EW, et al: Sustained increase in α5GABAA receptor function impairs memory after anesthesia. J Clin Invest. 124:5437–5441. 2014. View Article : Google Scholar : PubMed/NCBI
6.	Shipton OA and Paulsen O: GluN2A and GluN2B subunit-containing NMDA receptors in hippocampal plasticity. Philos Trans R Soc Lond B Biol Sci. 369:201301632013. View Article : Google Scholar : PubMed/NCBI
7.	Lee YS and Silva AJ: The molecular and cellular biology of enhanced cognition. Nat Rev Neurosci. 10:126–40. 2009. View Article : Google Scholar : PubMed/NCBI
8.	Rammes G, Starker LK, Haseneder R, Berkmann J, Plack A, Zieglgänsberger W, Ohl F, Kochs EF and Blobner M: Isoflurane anaesthesia reversibly improves cognitive function and long-term potentiation (LTP) via an up-regulation in NMDA receptor 2B subunit expression. Neuropharmacology. 56:626–636. 2009. View Article : Google Scholar : PubMed/NCBI
9.	Mawhinney LJ, de Rivero Vaccari JP, Alonso OF, Jimenez CA, Furones C, Moreno WJ, Lewis MC, Dietrich WD and Bramlett HM: Isoflurane/nitrous oxide anesthesia induces increases in NMDA receptor subunit NR2B protein expression in the aged rat brain. Brain Res. 1431:23–34. 2012. View Article : Google Scholar : PubMed/NCBI
10.	Chi H, Kawano T, Tamura T, Iwata H, Takahashi Y, Eguchi S, Yamazaki F, Kumagai N and Yokoyama M: Postoperative pain impairs subsequent performance on a spatial memory task via effects on N-methyl-D-aspartate receptor in aged rats. Life Sci. 93:986–993. 2013. View Article : Google Scholar : PubMed/NCBI
11.	Wang WY, Jia LJ, Luo Y, Zhang HH, Cai F, Mao H, Xu WC, Fang JB, Peng ZY, Ma ZW, et al: Location- and subunit-specific NMDA receptors determine the developmental sevoflurane neurotoxicity through ERK1/2 signaling. Mol Neurobiol. 53:216–230. 2016. View Article : Google Scholar : PubMed/NCBI
12.	Liu J, Zhang X, Zhang W, Gu G and Wang P: Effects of sevoflurane on young male adult C57BL/6 mice spatial cognition. PLoS One. 10:e01342172015. View Article : Google Scholar : PubMed/NCBI
13.	Ivanov A, Pellegrino C, Rama S, Dumalska I, Salyha Y, Ben-Ari Y and Medina I: Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons. J Physiol. 572:789–798. 2006. View Article : Google Scholar : PubMed/NCBI
14.	Hardingham GE and Bading H: Synaptic versus extrasynaptic NMDA receptor signalling: Implications for neurodegenerative disorders. Nat Rev Neurosci. 11:682–696. 2010. View Article : Google Scholar : PubMed/NCBI
15.	Soria FN, Pérez-Samartín A, Martin A, Gona KB, Llop J, Szczupak B, Chara JC, Matute C and Domercq M: Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage. JClin Invest. 124:3645–3655. 2014. View Article : Google Scholar
16.	Zhang X, Xin X, Dong Y, Zhang Y, Yu B, Mao J and Xie Z: Surgical incision-induced nociception causes cognitive impairment and reduction in synaptic NMDA receptor 2B in mice. J Neurosci. 33:17737–17748. 2013. View Article : Google Scholar : PubMed/NCBI
17.	Goebel-Goody SM, Davies KD, Alvestad Linger RM, Freund RK and Browning MD: Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices. Neuroscience. 158:1446–1459. 2009. View Article : Google Scholar : PubMed/NCBI
18.	Hudson AE and Hemmings HC Jr: Are anaesthetics toxic to the brain? Br J Anaesth. 107:30–7. 2011. View Article : Google Scholar : PubMed/NCBI
19.	Rappaport BA, Suresh S , Hertz S, Evers AS and Orser BA: Anesthetic neurotoxicity-clinical implications of animal models. N Engl J Med. 372:796–7. 2015.
20.	Brambrink AM, Orfanakis A and Kirsch JR: Anesthetic neurotoxicity. Anesthesiol Clin. 30:207–228. 2012. View Article : Google Scholar : PubMed/NCBI
21.	Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, Rabbitt P, Jolles J, Larsen K, Hanning CD, et al: Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International study of post-operative cognitive dysfunction. Lancet. 351:857–861. 1998. View Article : Google Scholar : PubMed/NCBI
22.	Newman S, Stygall J, Hirani S, Shaefi S and Maze M: Postoperative cognitive dysfunction after noncardiac surgery: A systematic review. Anesthesiology. 106:572–590. 2007. View Article : Google Scholar : PubMed/NCBI
23.	Nadelson MR, Sanders RD and Avidan MS: Perioperative cognitive trajectory in adults. Br J Anaesth. 112:440–451. 2014. View Article : Google Scholar : PubMed/NCBI
24.	Stratmann G, Sall JW, Bell JS, Alvi RS, May L, Ku B, Dowlatshahi M, Dai R, Bickler PE, Russell I, et al: Isoflurane does not affect brain cell death, hippocampal neurogenesis, or long-term neurocognitive outcome in aged rats. Anesthesiology. 112:305–315. 2010. View Article : Google Scholar : PubMed/NCBI
25.	Liu H and Weng H: Up-regulation of Alzheimer's disease-associated proteins may cause enflurane anesthesia induced cognitive decline in aged rats. Neurol Sci. 35:185–189. 2014. View Article : Google Scholar : PubMed/NCBI
26.	Selkoe DJ: Alzheimer's disease is a synaptic failure. Science. 298:789–791. 2002. View Article : Google Scholar : PubMed/NCBI
27.	Arendt T: Synaptic degeneration in Alzheimer's disease. Acta Neuropathol. 118:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
28.	Querfurth HW and LaFerla FM: Alzheimer's disease. N Engl J Med. 362:329–344. 2010. View Article : Google Scholar : PubMed/NCBI
29.	Shipton OA, Leitz JR, Dworzak J, Acton CE, Tunbridge EM, Denk F, Dawson HN, Vitek MP, Wade-Martins R, Paulsen O, et al: Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. J Neurosci. 31:1688–1692. 2011. View Article : Google Scholar : PubMed/NCBI
30.	Pooler AM, Noble W and Hanger DP: A role for tau at the synapse in Alzheimer's disease pathogenesis. Neuropharmacology. 76(Pt A): 1–8. 2014.doi: 10.1016/j.neuropharm.2013.09.018. View Article : Google Scholar : PubMed/NCBI
31.	Parsons MP and Raymond LA: Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron. 82:279–293. 2014. View Article : Google Scholar : PubMed/NCBI
32.	Nagy J: The NR2B subtype of NMDA receptor: a potential target for the treatment of alcohol dependence. Curr Drug Targets CNS Neurol Disord. 3:169–179. 2004. View Article : Google Scholar : PubMed/NCBI
33.	Ming Z, Griffith BL, Breese GR, Mueller RA and Criswell HE: Changes in the effect of isoflurane on N-methyl-D-aspartic acid-gated currents in cultured cerebral cortical neurons with time in culture: evidence for subunit specificity. Anesthesiology. 97:856–867. 2002. View Article : Google Scholar : PubMed/NCBI
34.	Liu DD, Yang Q and Li ST: Activation of extrasynaptic NMDA receptors induces LTD in rat hippocampal CA1 neurons. Brain Res Bull. 93:10–16. 2013. View Article : Google Scholar : PubMed/NCBI
35.	Li S, Jin M, Koeglsperger T, Shepardson NE, Shankar GM and Selkoe DJ: Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. J Neurosci. 31:6627–6638. 2011. View Article : Google Scholar : PubMed/NCBI
36.	Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G and Tsien JZ: Genetic enhancement of learning and memory in mice. Nature. 401:63691999.
37.	Hawasli AH, Benavides DR, Nguyen C, Kansy JW, Hayashi K, Chambon P, Greengard P, Powell CM, Cooper DC and Bibb JA: Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat Neurosci. 10:880–886. 2007. View Article : Google Scholar : PubMed/NCBI
38.	Zhao X, Rosenke R, Kronemann D, Brim B, Das SR, Dunah AW and Magnusson KR: The effects of aging on N-methyl-D-aspartate receptor subunits in the synaptic membrane and relationships to long-term spatial memory. Neuroscience. 162:933–945. 2009. View Article : Google Scholar : PubMed/NCBI
39.	Chen BS and Roche KW: Regulation of NMDA receptors by phosphorylation. Neuropharmacology. 53:3622007. View Article : Google Scholar : PubMed/NCBI
40.	Pehar M, Ko MH, Li M, Scrable H and Puglielli L: P44, the ‘longevity-assurance’ isoform of P53, regulates tau phosphorylation and is activated in an age-dependent fashion. Aging Cell. 13:449–456. 2014. View Article : Google Scholar : PubMed/NCBI
41.	Song WJ, Son MY, Lee HW, Seo H, Kim JH and Chung SH: Enhancement of BACE1 activity by p25/Cdk5-mediated phosphorylation in Alzheimer's disease. PLoS One. 10:e01369502015. View Article : Google Scholar : PubMed/NCBI
42.	Wang WY, Luo Y, Jia LJ, Hu SF, Lou XK, Shen SL, Lu H, Zhang HH, Yang R, Wang H, et al: Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain. Neuropharmacology. 77:90–99. 2014. View Article : Google Scholar : PubMed/NCBI
43.	Zhang S, Edelmann L, Liu J, Crandall JE and Morabito MA: Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors. J Neurosci. 28:415–424. 2008. View Article : Google Scholar : PubMed/NCBI
44.	Sato S, Xu J, Okuyama S, Martinez LB, Walsh SM, Jacobsen MT, Swan RJ, Schlautman JD, Ciborowski P and Ikezu T: Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1. J Neurosci. 28:14511–14521. 2008. View Article : Google Scholar : PubMed/NCBI
45.	Plattner F, Hernández A, Kistler TM, Pozo K, Zhong P, Yuen EY, Tan C, Hawasli AH, Cooke SF, Nishi A, et al: Memory enhancement by targeting Cdk5 regulation of NR2B. Neuron. 81:1070–1083. 2014. View Article : Google Scholar : PubMed/NCBI
46.	Howland JG and Cazakoff BN: Effects of acute stress and GluN2B-containing NMDA receptor antagonism on object and object-place recognition memory. Neurobiol Learn Mem. 93:261–267. 2010. View Article : Google Scholar : PubMed/NCBI
47.	Ge Y, Dong Z, Bagot RC, Howland JG, Phillips AG, Wong TP and Wang YT: Hippocampal long-term depression is required for the consolidation of spatial memory. Proc Natl Acad Sci USA. 107:16697–16702. 2010. View Article : Google Scholar : PubMed/NCBI
48.	Mathur P, Graybeal C, Feyder M, Davis MI and Holmes A: Fear memory impairing effects of systemic treatment with the NMDA NR2B subunit antagonist, Ro 25–6981, in mice: attenuation with ageing. Pharmacol Biochem Behav. 91:453–460. 2009. View Article : Google Scholar : PubMed/NCBI